BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 30655041)

  • 21. Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.
    Deguchi I; Takeda H; Furuya D; Dembo T; Nagoya H; Kato Y; Ito Y; Fukuoka T; Maruyama H; Tanahashi N
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):108-13. PubMed ID: 20851627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Study of Intravenous, Low-Dose Recombinant Tissue Plasminogen Activator for Acute Cerebral Infarction: Comparison of Treatment within 3 Hours versus 3-4.5 Hours.
    Deguchi I; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):1033-1040. PubMed ID: 29221968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study.
    Sekoranja L; Loulidi J; Yilmaz H; Lovblad K; Temperli P; Comelli M; Sztajzel RF
    Stroke; 2006 Jul; 37(7):1805-9. PubMed ID: 16763175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke.
    Grond M; Rudolf J; Schmülling S; Stenzel C; Neveling M; Heiss WD
    Arch Neurol; 1998 Apr; 55(4):466-9. PubMed ID: 9561973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracranial color duplex sonography as a first tool in the prognosis after thrombolytic therapy.
    Vassileva E; Klissurski M
    Int J Stroke; 2012 Jun; 7(4):364-5. PubMed ID: 22583527
    [No Abstract]   [Full Text] [Related]  

  • 26. Reperfusion seizures: a manifestation of cerebral reperfusion injury after administration of recombinant tissue plasminogen activator for acute ischemic stroke.
    Hafeez F; Razzaq MA; Levine RL; Ramirez MA
    J Stroke Cerebrovasc Dis; 2007; 16(6):273-7. PubMed ID: 18035246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endovascular Treatment in Patients with Persistent Internal Carotid Artery Occlusion after Intravenous Tissue Plasminogen Activator: A Clinical Effectiveness Study.
    Hong JH; Sohn SI; Kang J; Jang MU; Kim BJ; Han MK; Park TH; Park SS; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Cho KH; Kim JT; Choi JC; Lee J; Lee JS; Gorelick PB; Bae HJ
    Cerebrovasc Dis; 2016; 42(5-6):387-394. PubMed ID: 27359223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute basilar artery occlusion treated with combined intravenous Abciximab and intra-arterial tissue plasminogen activator: report of 3 cases.
    Eckert B; Koch C; Thomalla G; Roether J; Zeumer H
    Stroke; 2002 May; 33(5):1424-7. PubMed ID: 11988626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era.
    Endo K; Koga M; Sakai N; Yamagami H; Furui E; Matsumoto Y; Shiokawa Y; Yoshimura S; Okada Y; Nakagawara J; Hyogo T; Hasegawa Y; Nagashima H; Fujinaka T; Hyodo A; Terada T; Toyoda K;
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intravenous thrombolytic treatment of acute basilar artery occlusion].
    Eldøen G; Thomassen L; Johnsen HJ; Schrader H; Moen G
    Tidsskr Nor Laegeforen; 2001 Sep; 121(22):2599-600. PubMed ID: 11668757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staged escalation therapy in acute basilar artery occlusion: intravenous thrombolysis and on-demand consecutive endovascular mechanical thrombectomy: preliminary experience in 16 patients.
    Pfefferkorn T; Mayer TE; Opherk C; Peters N; Straube A; Pfister HW; Holtmannspötter M; Müller-Schunk S; Wiesmann M; Dichgans M
    Stroke; 2008 May; 39(5):1496-500. PubMed ID: 18323481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion.
    Yeo LL; Kong WY; Paliwal P; Teoh HL; Seet RC; Soon D; Rathakrishnan R; Ong V; Lee TH; Wong HF; Chan BP; Leow WK; Yuan C; Ting E; Gopinathan A; Tan BY; Sharma VK
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2423-9. PubMed ID: 27344361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple hypointense vessels on susceptibility-weighted imaging predict early neurological deterioration in acute ischaemic stroke patients with severe intracranial large artery stenosis or occlusion receiving intravenous thrombolysis.
    Liu YL; Yin HP; Qiu DH; Qu JF; Zhong HH; Lu ZH; Wang F; Liang MQ; Chen YK
    Stroke Vasc Neurol; 2020 Dec; 5(4):361-367. PubMed ID: 32586972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term magnetic resonance angiography follow-up for recanalized vessels after mechanical thrombectomy.
    Enomoto Y; Yoshimura S; Egashira Y; Takagi T; Tsujimoto M; Iwama T
    J Stroke Cerebrovasc Dis; 2014; 23(10):2834-2839. PubMed ID: 25440365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome.
    Eckert B; Kucinski T; Neumaier-Probst E; Fiehler J; Röther J; Zeumer H
    Cerebrovasc Dis; 2003; 15(4):258-63. PubMed ID: 12686789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serendipitous recanalization of basilar artery occlusion.
    Switzer JA; Forseen SE; Bruno A; Hess DC
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e671-3. PubMed ID: 23834852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three cases of middle cerebral artery occlusion emergently revascularized with a balloon-expandable coronary bare stent after intravenous tissue plasminogen activator.
    Fukuoka T; Dembo T; Nagoya H; Deguchi I; Maruyama H; Kanazawa R; Kohyama S; Yamane F; Ishihara S; Tanahashi N
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):883-9. PubMed ID: 21767964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment Blood Pressure is a Simple Predictor of Hemorrhagic Infarction after Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) Therapy.
    Ohtani R; Nakamura M; Nirengi S; Kawakami O; Togawa J; Doi K; Sainouchi M; Kuwata Y; Takata M; Masuda Y; Matsunari R; Takeda K; Tsukahara T; Sakane N
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1979-1986. PubMed ID: 30982718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.